122 filings
Page 4 of 7
8-K
v829xq9zocb7vnjd3m7q
16 May 22
Vivos Therapeutics Reports First Quarter 2022
4:10pm
8-K
pie1n69j2691b
31 Mar 22
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
5:13pm
8-K
n8lx3t
1 Mar 22
Departure of Directors or Certain Officers
5:15pm
EFFECT
3ti2qd8jkplhmtj
15 Feb 22
Notice of effectiveness
12:15am
CORRESP
90bsssc
14 Feb 22
Correspondence with SEC
12:00am
UPLOAD
tsd4m1u9rf47l 5hj
14 Feb 22
Letter from SEC
12:00am
S-3
yqz6b6pe5
7 Feb 22
Shelf registration
9:33am
8-K
6xie81kb43me4es
15 Nov 21
Vivos Therapeutics Reports Third Quarter 2021 Financial Results
4:15pm
8-K
7mw5v epeexv99u
27 Sep 21
Entry into a Material Definitive Agreement
9:00am
8-K
z91 x5tcm7uy
12 Aug 21
Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update
4:15pm
8-K
mthwk mqs
29 Jul 21
Submission of Matters to a Vote of Security Holders
4:15pm
DEF 14A
yc4o 1jsk
29 Jun 21
Definitive proxy
4:38pm
8-K
0u3cfpr6ubzso vnn36
17 Jun 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:01pm
S-8
c6vlsm4ycc surkvrk9
11 Jun 21
Registration of securities for employees
5:16pm
EFFECT
jfj2ml743jg0mvs9
20 May 21
Notice of effectiveness
12:15am
424B4
6krffi46a6
19 May 21
Prospectus supplement with pricing info
5:30pm